Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103118692 | 10311869 | 2 | F | 20160713 | 20140717 | 20160715 | EXP | NL-BRISTOL-MYERS SQUIBB COMPANY-21197140 | BRISTOL MYERS SQUIBB | 46.00 | YR | M | Y | 0.00000 | 20160715 | CN | DE | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103118692 | 10311869 | 1 | PS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, QD | Y | 20357 | 500 | MG | QD | ||||||
| 103118692 | 10311869 | 2 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 12.5 MG, QD | Y | 0 | 12.5 | MG | QD | ||||||
| 103118692 | 10311869 | 3 | SS | ENALAPRIL | ENALAPRIL | 1 | Unknown | 20 MG, QD | Y | 0 | 20 | MG | QD | ||||||
| 103118692 | 10311869 | 4 | SS | OMEPRAZOL E | OMEPRAZOLE | 1 | Unknown | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 103118692 | 10311869 | 5 | SS | LACTULOSE. | LACTULOSE | 1 | Unknown | 40 G, TID | Y | 0 | 40 | G | TID | ||||||
| 103118692 | 10311869 | 6 | SS | PEGINTERFERON ALFA-2A | PEGINTERFERON ALFA-2A | 1 | Unknown | 180 ?G, QWK | Y | 0 | 180 | UG | /wk | ||||||
| 103118692 | 10311869 | 7 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | 600 MG, BID | Y | 0 | 600 | MG | BID | ||||||
| 103118692 | 10311869 | 8 | I | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 80 MG, QD | Y | 0 | 80 | MG | QD | ||||||
| 103118692 | 10311869 | 9 | I | TELAPREVIR | TELAPREVIR | 1 | Unknown | 750 MG, TID | Y | 0 | 750 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103118692 | 10311869 | 1 | Product used for unknown indication |
| 103118692 | 10311869 | 2 | Product used for unknown indication |
| 103118692 | 10311869 | 3 | Product used for unknown indication |
| 103118692 | 10311869 | 4 | Product used for unknown indication |
| 103118692 | 10311869 | 5 | Product used for unknown indication |
| 103118692 | 10311869 | 6 | Chronic hepatitis C |
| 103118692 | 10311869 | 7 | Chronic hepatitis C |
| 103118692 | 10311869 | 8 | Product used for unknown indication |
| 103118692 | 10311869 | 9 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103118692 | 10311869 | HO |
| 103118692 | 10311869 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103118692 | 10311869 | Bacterial infection | |
| 103118692 | 10311869 | Drug interaction | |
| 103118692 | 10311869 | Oedema | |
| 103118692 | 10311869 | Pyrexia | |
| 103118692 | 10311869 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |